CR11141A - PHARMACEUTICAL AND COSMETOLOGICAL COMPOSITIONS WITH EXTRACT BASE OF MEDICINAL BLOODS AND SYNERGIST MEDICINAL PLANTS - Google Patents

PHARMACEUTICAL AND COSMETOLOGICAL COMPOSITIONS WITH EXTRACT BASE OF MEDICINAL BLOODS AND SYNERGIST MEDICINAL PLANTS

Info

Publication number
CR11141A
CR11141A CR11141A CR11141A CR11141A CR 11141 A CR11141 A CR 11141A CR 11141 A CR11141 A CR 11141A CR 11141 A CR11141 A CR 11141A CR 11141 A CR11141 A CR 11141A
Authority
CR
Costa Rica
Prior art keywords
medicinal
bloods
synergist
pharmaceutical
extract base
Prior art date
Application number
CR11141A
Other languages
Spanish (es)
Inventor
Pavlovich Saltykov Saltykova Victor
Original Assignee
Víctor Pavlovich Saltykov Saltykova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Víctor Pavlovich Saltykov Saltykova filed Critical Víctor Pavlovich Saltykov Saltykova
Priority to CR11141A priority Critical patent/CR11141A/en
Publication of CR11141A publication Critical patent/CR11141A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Se trata de la utilización de composiciones de las sustancias activas, mencionadas en el título de la invención, para el tratamiento de diferentes condiciones patológicas caracterizadas por insuficiencia circulatoria.It concerns the use of compositions of the active substances, mentioned in the title of the invention, for the treatment of different pathological conditions characterized by circulatory insufficiency.

CR11141A 2009-12-02 2009-12-02 PHARMACEUTICAL AND COSMETOLOGICAL COMPOSITIONS WITH EXTRACT BASE OF MEDICINAL BLOODS AND SYNERGIST MEDICINAL PLANTS CR11141A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR11141A CR11141A (en) 2009-12-02 2009-12-02 PHARMACEUTICAL AND COSMETOLOGICAL COMPOSITIONS WITH EXTRACT BASE OF MEDICINAL BLOODS AND SYNERGIST MEDICINAL PLANTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR11141A CR11141A (en) 2009-12-02 2009-12-02 PHARMACEUTICAL AND COSMETOLOGICAL COMPOSITIONS WITH EXTRACT BASE OF MEDICINAL BLOODS AND SYNERGIST MEDICINAL PLANTS

Publications (1)

Publication Number Publication Date
CR11141A true CR11141A (en) 2011-01-21

Family

ID=51359504

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11141A CR11141A (en) 2009-12-02 2009-12-02 PHARMACEUTICAL AND COSMETOLOGICAL COMPOSITIONS WITH EXTRACT BASE OF MEDICINAL BLOODS AND SYNERGIST MEDICINAL PLANTS

Country Status (1)

Country Link
CR (1) CR11141A (en)

Similar Documents

Publication Publication Date Title
MX2015003140A (en) Formulations of enzalutamide.
CL2013003372A1 (en) Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes.
CO7101245A2 (en) Substituted benzaldehyde compounds and methods for use in increasing tissue oxygenation
EA201591166A1 (en) AUTOTAXIN INHIBITORS
MX2015011445A (en) Compounds and uses thereof for the modulation of hemoglobin.
CL2013001654A1 (en) Compounds derived from 6-amino-2-phenylamino-1h-benzimidazol-5-carboxamide; pharmaceutical composition; and its use in the treatment and / or prevention of inflammatory diseases and / or associated conditions, in particular pain.
PE20180318A1 (en) PROCEDURE FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
EA201591427A1 (en) COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN
CL2013000018A1 (en) Compounds derived from indolizine, their preparation procedure; pharmaceutical composition; and use in the treatment of cancer, among others.
MX2015009104A (en) COMPOSITIONS IN SOLID SOLUTION AND USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES.
BR112015003397A2 (en) compound, pharmaceutical composition, use of the compound and method for treating a rorgammat-mediated disease or condition in a patient.
CL2014001158A1 (en) Alkylated piperazine derivative compounds; pharmaceutical composition that includes them; process to prepare the pharmaceutical composition; kit and use in the treatment of immune disorders, cancer, cardiovascular diseases, inflammation, among others.
MX2015011448A (en) COMPOUNDS AND THEIR USES TO MODULATE HEMOGLOBIN.
CR20140200A (en) SOLID FORMS OF 3- (5-AMINO-2-METHYL-4-OXO-AH-QUINAZOLIN-3-IL) -PIPERIDIN-2,6-DIONA, AND ITS PHARMACEUTICAL COMPOSITIONS AND THEIR USES
MX2019000588A (en) Somatostatin modulators and uses thereof.
CR11731A (en) COMPOSITIONS AND PROCEDURES FOR PREPARATION AND USE
MX2015011769A (en) COMPOUNDS AND THEIR USES TO MODULATE HEMOGLOBIN.
BRPI1012116A2 (en) pharmaceutical composition for the treatment of heart disease
UY34545A (en) NOVEDOSE DIHYDROPIRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME FOR THE TREATMENT OF INFLAMMATORY DISORDERS.
HUE053113T2 (en) Bardoxolone-methyl 2,2-difluoropropionamide derivative, its pharmaceutical compositions and polymorphs for use in the treatment of certain diseases
BR112014021531A8 (en) compound, pharmaceutical composition and uses thereof
CL2016001918A1 (en) Heteroaryl amides as protein aggregation inhibitors
AR092330A1 (en) COMPOSITIONS, METHODS OF TRANSMUCOUS ABSORPTION AND TREATMENT METHOD
GT201400085A (en) ADRENOMEDULINE PROMOTE BASED ON POLYETHYLENE GLYCOL AND ITS USE
EA201992707A1 (en) COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION